Skip to main content

Healthcare Royalty, Inc. (HCRX)

Healthcare Royalty was planning to go public, but the IPO has been postponed.
Stock Price: $15.00 - $17.00
Current IPO price range
Chart not available yet
Market Cap3.45B
Revenue (ttm)263.48M
Net Income (ttm)322.81M
Shares Out215.50M
EPS (ttm)1.50
PE Ratio10.68
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Openn/a
Previous Closen/a
Day's Rangen/a
52-Week Rangen/a
Betan/a
Analystsn/a
Price Targetn/a
Est. Earnings Daten/a

About HCRX

Healthcare Royalty is the leading mid-market royalty acquisition company, based upon the number of transactions and aggregate value of capital deployed since 2016. We focus on growth assets and emerging companies driving innovation in the biopharmaceutical industry. Our mission is to facilitate innovation by deploying capital consistently and reliably in products that serve unmet or underserved medical needs. We intend to achieve this mission by expanding our portfolio of approved and pre-approval products using cash flow generated by our exist...

IndustryBiotechnology
IPO DatePostponed
CEOClarke B. Futch
Employees25
Stock ExchangeNASDAQ
Ticker SymbolHCRX
Full Company Profile

Financial Performance

In 2020, HCRX's revenue was $228.83 million, an increase of 29.06% compared to the previous year's $177.31 million. Earnings were $253.25 million, an increase of 46.77%.

Financial Statements

News

HealthCare Royalty, Inc. Launches Initial Public Offering

HealthCare Royalty, Inc. (together with its subsidiaries, “HCR” or the “Company”) today announced that it has...

1 month ago - GlobeNewswire

Healthcare Royalty IPO Registration Document (S-1)

Healthcare Royalty, Inc. has filed to go public with an IPO on the NASDAQ.

2 months ago - SEC